Skin cancer in organ transplant recipients: effects of immunosuppressive medications on DNA repair

Rapamycin Is a Potent Inhibitor of Skin Tumor Promotion by 12-O-Tetradecanoylphorbol-13-Acetate

(2011) L. Allyson Checkley et al.   Cancer Prevention Research

Cyclosporin A inhibits nucleotide excision repair via downregulation of the xeroderma pigmentosum group A and G proteins, which is mediated by calcineurin inhibition

(2011) Christiane Kuschal et al.   EXPERIMENTAL DERMATOLOGY

Cyclosporin A, but not everolimus, inhibits DNA repair mediated by calcineurin: implications for tumorigenesis under immunosuppression

(2011) Kai-Martin Thoms et al.   EXPERIMENTAL DERMATOLOGY

Organ transplantation and skin cancer: basic problems and new perspectives

(2010) Günther F.L. Hofbauer et al.   EXPERIMENTAL DERMATOLOGY

Mechanisms of mutation formation with long-wave ultraviolet light (UVA)

(2010) Thomas M. Rünger et al.   PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE

The mTOR Inhibitor Rapamycin Suppresses DNA Double-Strand Break Repair

(2010) Honghong Chen et al.   RADIATION RESEARCH

Expression of DNA mismatch repair proteins and MSH2 polymorphisms in nonmelanoma skin cancers of organ transplant recipients

(2009) C.M. Perrett et al.   BRITISH JOURNAL OF DERMATOLOGY

Immune Effector Cells Produce Lethal DNA Damage in Cells Treated with a Thiopurine

(2009) I. Daehn et al.   CANCER RESEARCH

The role of the retinoblastoma/E2F1 tumor suppressor pathway in the lesion recognition step of nucleotide excision repair

(2009) Patrick S. Lin et al.   DNA REPAIR

Immunosuppressive Drugs in Kidney Transplantation

(2009) Roberto Marcén   DRUGS

Checkpoint Kinase ATR Promotes Nucleotide Excision Repair of UV-induced DNA Damage via Physical Interaction with Xeroderma Pigmentosum Group A

(2009) Steven M. Shell et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Significant response after treatment with the mTOR inhibitor sirolimus in combination with carboplatin and paclitaxel in metastatic melanoma patients

(2009) Friedegund Meier et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Cyclosporine A suppresses keratinocyte cell death through MPTP inhibition in a model for skin cancer in organ transplant recipients

(2009) Kimberly G. Norman et al.   MITOCHONDRION

PP2A regulates ionizing radiation-induced apoptosis through Ser46 phosphorylation of p53

(2009) J. Mi et al.   MOLECULAR CANCER THERAPEUTICS

Reactive oxygen species generated by thiopurine/UVA cause irreparable transcription-blocking DNA lesions

(2009) R. Brem et al.   NUCLEIC ACIDS RESEARCH

Rapamycin Inhibits Yeast Nucleotide Excision Repair Independently of Tor Kinases

(2009) Melvin V. Limson et al.   TOXICOLOGICAL SCIENCES

Molecular Concepts of Virus Infections Causing Skin Cancer in Organ Transplant Recipients

(2008) I. Nindl et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Skin Cancer in Organ Transplant Recipients-Where Do We Stand Today?

(2008) C. Ulrich et al.   AMERICAN JOURNAL OF TRANSPLANTATION

PTCH mutations in basal cell carcinomas from azathioprine-treated organ transplant recipients

(2008) C A Harwood et al.   BRITISH JOURNAL OF CANCER

More epidermal p53 patches adjacent to skin carcinomas in renal transplant recipients than in immunocompetent patients: the role of azathioprine

(2007) Ymke G. L. de Graaf et al.   EXPERIMENTAL DERMATOLOGY